Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea

• Main Authors: Nam-Jun Cho (Author), Dae-Yeon Kim (Author), Soon Hyo Kwon (Author), Tae Won Ha (Author), Hyun Kyu Kim (Author), Man Ryul Lee (Author), Sung Wan Chun (Author), Samel Park (Author), Eun-young Lee (Author), Hyo-Wook Gil (Author)
• Format: Book
• Published: The Korean Society of Nephrology, 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Dipeptidyl peptidase-4 (DPP-4) inhibitor has been reported to have kidney-protective benefits. To elucidate how antidiabetic agents prevent diabetic kidney disease progression, it is important to investigate their effect on the kidney environment in type 2 diabetes mellitus (DM) patients....